معرفی
Francois Mullier is a Research Professor at the University of Namur, specializing in Clinical Pharmacology and Toxicology. He actively contributes to thrombosis and hemostasis research through the Namur Thrombosis and Hemostasis Center and Namur MEdicine & Drug Innovation Center. His work focuses on anticoagulant therapy, coagulation assays, and drug-induced thrombosis.
- Key Affiliations: University of Namur, Namur Thrombosis and Hemostasis Center, Namur MEdicine & Drug Innovation Center
- Research Themes: Anticoagulant pharmacology, Thrombosis mechanisms, Clinical hemostasis testing
Dr. Mullier’s recent publications highlight his expertise in evaluating new anticoagulant agents like asundexian, analyzing preanalytical variables in fibrin metabolism testing, and assessing the sustainability of laboratory practices. His work bridges pharmacology and clinical hematology, emphasizing drug safety and diagnostic accuracy.
Scientific contributions include a 2017 Prix Léo Pharma Cancer & Thrombosis for his research on tyrosine kinase inhibitors. He has supervised projects on drug-induced thrombosis and coagulation assay validation, collaborating with institutions like Catholic University Louvain (UCLouvain). His research outputs span Research and Practice in Thrombosis and Haemostasis, International Journal of Laboratory Hematology, and The Journal of Applied Laboratory Medicine.
